Olivier Taelman
Chief Executive Officer at NYXOAH SA
Net worth: 6 M $ as of 31/03/2024
Profile
Olivier Taelman is currently the Chief Executive Officer & Executive Director at Nyxoah SA. Prior to his current position, he worked as the Business Director-Neuromodulation at Nevro Corp.
from 2013 to 2015, and as the Vice President-Europe at Autonomic Technologies, Inc. from 2015 to 2019.
Mr. Taelman completed his undergraduate degree at Hasselt University and holds an MBA from The Wharton School of the University of Pennsylvania.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NYXOAH SA
1.47% | 18/03/2024 | 419,930 ( 1.47% ) | 6 M $ | 31/03/2024 |
Olivier Taelman active positions
| Companies | Position | Start |
|---|---|---|
| NYXOAH SA | Chief Executive Officer | 01/11/2019 |
Former positions of Olivier Taelman
| Companies | Position | End |
|---|---|---|
Autonomic Technologies, Inc.
 Autonomic Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Autonomic Technologies, Inc. develops and commercializes innovative therapies for the treatment of severe headache. Its product, the ATI Neurostimulation System, is used for the treatment of acute pain of cluster headache. The company was founded in 2007 and is headquartered in Redwood City, CA. | Corporate Officer/Principal | 01/11/2019 |
| NEVRO CORP. | Corporate Officer/Principal | 01/12/2015 |
Training of Olivier Taelman
| Hasselt University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| NEVRO CORP. | Health Technology |
| NYXOAH SA | Health Technology |
| Private companies | 1 |
|---|---|
Autonomic Technologies, Inc.
Autonomic Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Autonomic Technologies, Inc. develops and commercializes innovative therapies for the treatment of severe headache. Its product, the ATI Neurostimulation System, is used for the treatment of acute pain of cluster headache. The company was founded in 2007 and is headquartered in Redwood City, CA. | Electronic Technology |
- Stock Market
- Insiders
- Olivier Taelman
